Incorporating model uncertainty in detecting rare variants: the Bayesian risk index
Related Experiment Video
Updated: May 28, 2026

An R-Based Landscape Validation of a Competing Risk Model
Published on: September 16, 2022
Melanie A Quintana1, Jonine L Berstein, Duncan C Thomas
1Department of Preventive Medicine, Division of Biostatistics, University of Southern California, Los Angeles, California, USA. wilsonme@usc.edu
Abstract:
We are interested in investigating the involvement of multiple rare variants within a given region by conducting analyses of individual regions with two goals: (1) to determine if regional rare variation in aggregate is associated with risk; and (2) conditional upon the region being associated, to identify specific genetic variants within the region that are driving the association. In particular, we seek a formal integrated analysis that achieves both of our goals. For rare variants with low minor allele frequencies, there is very little power to statistically test the null hypothesis of equal allele or genotype counts for each variant. Thus, genetic association studies are often limited to detecting association within a subset of the common genetic markers. However, it is very likely that associations exist for the rare variants that may not be captured by the set of common markers. Our framework aims at constructing a risk index based on multiple rare variants within a region. Our analytical strategy is novel in that we use a Bayesian approach to incorporate model uncertainty in the selection of variants to include in the index as well as the direction of the associated effects. Additionally, the approach allows for inference at both the group and variant-specific levels. Using a set of simulations, we show that our methodology has added power over other popular rare variant methods to detect global associations. In addition, we apply the approach to sequence data from the WECARE Study of second primary breast cancers.
Related Concept Videos
Uncertainty: Confidence Intervals
Propagation of Uncertainty from Random Error
Relative Risk
Propagation of Uncertainty from Systematic Error
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Confidence Intervals
A confidence...

